(MedPage Today) -- SILVER SPRING, Md. -- Patients starting on the sleep drug eszopiclone (Lunesta) should take no more than 1 mg at bedtime -- one-third the current label-recommended dose -- because of the risk of next-day impairment, the FDA said Thursday.

Our Practice Philosophy

We are proud to provide traditional, conservative health care in alignment with guidelines and recommendations provided by the American Academy of Pediatrics.

We are an Evidence-Based Practice (EBP) and believe in Evidence Based Treatment (EBT). EBT's are treatments that are based directly on scientific evidence. In other words, research studies have shown that some treatments work better than others for specific problems that children and adolescents experience. Hence we provide you with the highest quality of medical care, firmly grounded on established and time-tested medical practices and research. This philosophy governs our actions in many areas of medical care-giving like recommended Vaccination schedule compliance for childhood immunizations, use of prescriptions, and avoidance of alternative treatment regimens etc.